VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GNTA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GNTAGenenta Science S.p.A.
$1.80$34M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGNTABalance Sheet

Genenta Science S.p.A. (GNTA) Balance Sheet

7Y historyFree accessUpdated daily

Genenta Science S.p.A. (GNTA) annual balance sheet — 7-year assets, liabilities & equity history

GNTA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets29.98M14.47M21.26M31.72M38.76M16.53M20.6M
Cash & Short-Term Investments28.15M12.66M18.78M29.79M37.24M15.47M20.14M
Cash Only5.53M4.58M3.69M29.79M37.24M15.47M20.14M
Short-Term Investments22.62M8.08M15.08M0000
Accounts Receivable1.29M1.45M2M1.56M1.42M00
Days Sales Outstanding-------
Inventory000144.69K76.26K27.67K-163.49K
Days Inventory Outstanding---8.81K5.46K5.71K-
Other Current Assets337.44K210.83K64.66K115.86K3.74K1.01M593.08K
Total Non-Current Assets1.91M351.02K1.09M1.72M1.27M967.94K748.68K
Property, Plant & Equipment22.46K42.92K57.03K111.64K23.09K18.97K0
Fixed Asset Turnover-------
Goodwill0000000
Intangible Assets087.8K53.14K88000
Long-Term Investments0000000
Other Non-Current Assets1.89M220.29K980.71K1.6M1.24M948.97K748.68K
Total Assets31.89M14.82M22.35M33.44M40.03M17.5M21.35M
Asset Turnover-------
Asset Growth %115.12%-33.66%-33.17%-16.46%128.7%-18.02%-
Total Current Liabilities2.12M2.1M1.74M2.18M1.14M2.33M2.49M
Accounts Payable1.51M317.83K294.98K1.19M189.87K555.01K572.44K
Days Payables Outstanding20.42K2.49K2.58K72.69K13.6K114.58K-
Short-Term Debt0000000
Deferred Revenue (Current)0000000
Other Current Liabilities119K324.36K255.06K297.88K100.72K53.24K48K
Current Ratio14.16x6.89x12.25x14.53x34.15x7.09x8.29x
Quick Ratio14.16x6.89x12.25x14.46x34.08x7.07x8.35x
Cash Conversion Cycle-------
Total Non-Current Liabilities7.93M228.93K179.25K116.18K30.62K17.39K11.33K
Long-Term Debt7.6M000000
Capital Lease Obligations01.2K00000
Deferred Tax Liabilities0000000
Other Non-Current Liabilities327.79K227.72K179.25K116.18K30.62K17.39K11.33K
Total Liabilities10.05M2.33M1.91M2.3M1.17M2.35M2.5M
Total Debt7.6M14.6K00000
Net Debt2.08M-4.57M-3.69M-29.79M-37.24M-15.47M-20.14M
Debt / Equity0.35x0.00x-----
Debt / EBITDA-------
Net Debt / EBITDA-------
Interest Coverage-15.32x------
Total Equity21.84M12.5M20.43M31.14M38.86M15.15M18.85M
Equity Growth %74.79%-38.84%-34.38%-19.87%156.49%-19.63%-
Book Value per Share1.110.681.121.712.130.841.04
Total Shareholders' Equity21.84M12.5M20.43M31.14M38.86M15.15M18.85M
Common Stock84.26M68.46M67.34M66.6M65.88M37.06K36.05K
Retained Earnings-62.59M-56.06M-47.14M-35.47M-27.02M-21.49M-15.9M
Treasury Stock0000000
Accumulated OCI166.51K88.95K231.14K0000
Minority Interest0000000

GNTA — Frequently Asked Questions

Quick answers to the most common questions about buying GNTA stock.

What are the total assets of Genenta Science S.p.A. (GNTA)?

As of 2025, Genenta Science S.p.A. (GNTA) had total assets of $31.9M including $30.0M in current assets.

How much debt does Genenta Science S.p.A. (GNTA) have?

Genenta Science S.p.A. (GNTA) carries total debt of $7.6M, offset by $28.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Genenta Science S.p.A.?

Genenta Science S.p.A. (GNTA) has total shareholders' equity (book value) of $21.8M ($1.11 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Genenta Science S.p.A.'s current ratio and liquidity?

Genenta Science S.p.A. (GNTA) reported a current ratio of 14.16x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.